Doctors and scientists want drug regulators and research funding agencies to consider medicines that delay ageing-related disease as legitimate drugs. Such treatments have a physiological basis, researchers say, and could extend a person’s healthy years by slowing down the processes…
A vertical green field, multimedia installations and the stories of industrious people, cutting-edge technologies and thriving companies that made the desert blossom. At Expo Milano 2015 Israel will present the Fields of Tomorrow. From the creation of the “Super Wheat”,…
Clinical trials of a new drug cocktail have been shown to cure 58 percent of terminally-ill patients by shrinking cancerous tumors or eliminating them altogether. The scientific community is hailing this discovery as a major breakthrough in cancer research. The new…
Cancer and big data: Symposium WIN 2015, full program Israeli delegation at WIN Symposium 2015
Chief Scientist at the Israeli Ministry of Economy Avi Hasson signed a cooperation agreement with the Inter-American Development Bank (IDB) recently. The agreement will open new business opportunities for Israeli companies in Latin America. The Inter-American Development Bank is the…
Americans spend over $10 billion a year on products and surgery in their quest to find a “fountain of youth,” with little permanent success. Botulinum toxin — notably Botox — which smoothes lines and wrinkles to rejuvenate the aging face…
New Zealander Melissa Rodrigues’ three-year-old son claimed he heard an intruder. The first time she didn’t believe him. The second time, he showed her the proof – footprints in the mud. The third time the intruder appeared, Melissa and her…
SalesPredict’s underlying technology combines machine learning and natural language processing with predictive analytics. The platform continuously analyzes your sales win/loss data and correlates it with demographic, firmographic, and behavioral data from your CRM, marketing automation system, external data sources, and the open web to uncover…
A hereditary autoimmune disease that was thought to be exceedingly rare may have a less severe form that affects one in 1,000 people or even more, according to new research conducted at the Weizmann Institute of Science, in Israel, and…
At WIN Symposium in Paris 29-30th June 2015, attendees will hear the latest about cancer research and precision cancer medicine from global key opinion leaders: James Allison, James Doroshow, Andrea Califano, John Mendelsohn, Francesco Pignatti and others. View the final WIN Symposium…
